INVO Bioscience Announces Closing of 4.5 Million Public Offering
| INVODelisted Stock | USD 0.72 0.02 2.70% |
About 61% of INVO Bioscience's investor base is looking to short. The analysis of current outlook of investing in INVO Bioscience suggests that many traders are alarmed regarding INVO Bioscience's prospects. INVO Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in INVO Bioscience. Many technical investors use INVO Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
INVO |
INVO Bioscience, Inc. , a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell medical device and the intravaginal culture procedure it enables, today announced the closing of its public offering of 1,580,000 units, with each unit consisting of one share of common stock and two warrants, each to purchase one share of common stock. Each unit was sold at a public offering price of 2.85.
Read at finance.yahoo.com
 |
INVO Bioscience Fundamental Analysis
We analyze INVO Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INVO Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INVO Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
INVO Bioscience is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
INVO Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INVO Bioscience stock to make a market-neutral strategy. Peer analysis of INVO Bioscience could also be used in its relative valuation, which is a method of valuing INVO Bioscience by comparing valuation metrics with similar companies.
Peers
INVO Bioscience Related Equities
| ENTX | Entera Bio | 19.56 | ||||
| LIXT | Lixte Biotechnology | 4.95 | ||||
| ENVB | Enveric Biosciences | 2.56 | ||||
| NLSP | NLS Pharmaceutics | 0.92 | ||||
| CLPS | CLPS | 3.45 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |